Wolverine Trading, LLC Cel Sci Corp Call Options Transaction History

Wolverine Trading, LLC

13 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2023 Nov 15, 2023	SELL	$1.17 - $2.86 $8,307 - $20,306	-7,100 Reduced 36.98%	12,100 $15,000
Q2 2023 Aug 23, 2023	BUY	$2.11 - $2.83 $13,504 - $18,112	6,400 Added 50.0%	19,200 $46,000
Q1 2023 May 15, 2023	BUY	$2.17 - $3.13 $27,776 - $40,064	12,800 New	12,800 $30,000
Q2 2022 Aug 15, 2022	BUY	$2.58 - $4.99 $25,800 - $49,900	10,000 Added 52.63%	29,000 $128,000
Q1 2022 May 16, 2022	SELL	$3.93 - $7.7 $89,997 - $176,330	-22,900 Reduced 54.65%	19,000 $75,000
Q4 2021 Feb 14, 2022	SELL	$7.1 - $12.82 $52,540 - $94,868	-7,400 Reduced 15.01%	41,900 $315,000
Q3 2021 Nov 12, 2021	BUY	$7.64 - $12.49 $23,684 - $38,719	3,100 Added 6.71%	49,300 $544,000
Q2 2021 Aug 06, 2021	SELL	$8.68 - $27.49 $328,104 - $1.04 Million	-37,800 Reduced 45.0%	46,200 $593,000
Q1 2021 May 14, 2021	BUY	$12.0 - $27.64 $1.01 Million - $2.32 Million	84,000 New	84,000 $1.3 Million
Q4 2020 Feb 12, 2021	SELL	$11.05 - $16.62 $564,655 - $849,282	-51,100 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$11.69 - $14.54 $136,773 - $170,118	-11,700 Reduced 18.63%	51,100 $630,000
Q2 2020 Aug 13, 2020	BUY	$9.75 - $17.6 $472,875 - $853,600	48,500 Added 339.16%	62,800 $988,000
Q1 2020 May 11, 2020	BUY	$7.54 - $17.05 $107,822 - $243,815	14,300 New	14,300 $169,000

27.1K

150K

Ticker CVM
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,367,500
Market Cap $24.3M
Description
CEL-SCI Corporation engages in the research and development of immunotherapy for the treatment of cancer and infectious diseases. The company's lead investigational immunotherapy is Multikine, which is under phase III clinical trial for the treatment of head and neck cancer. Its Ligand Epitope Antigen Presentation System (LEAPS), a pre-clinical ...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.